New research shows diabetes and worse blood sugar control are associated with long-term cognitive decline

January 25, 2018, Diabetologia

A new study of some 5,000 older people in the UK has shown that rates of long-term cognitive decline are steeper in those who have diabetes compared with people with normal blood sugar control, and that efforts to delay the onset of diabetes and/or control blood sugar levels might prevent subsequent progression of brain function decline.

The study, based on the English Longitudinal Study of Ageing, is by Dr Wuxiang Xie, School of Public Health, Imperial College London, London, UK, and Peking University Clinical Research Institute, Beijing, China, and colleagues, and is published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD).

While other studies have linked with , this study is one of the largest to establish the direct relationship between HbA1c (levels of glycated haemoglobin, a measure of overall blood sugar control) and subsequent risk of cognitive decline.

The authors used data from wave 2 (2004-2005) to wave 7 (2014-2015) of the English Longitudinal Study of Ageing (ELSA) for their analysis. Cognitive function was assessed at baseline (wave 2) and reassessed every 2 years at waves 3-7. Computer modelling was then used to establish any possible associations.

The study contained 5189 participants (55% women, mean age 66 years) with baseline HbA1c levels ranging from 15.9 to 126.3 mmol/mol (3.6-13.7%). Current cut-offs for defining diabetes using HbA1c are 6.5% and above.

The mean follow-up duration was eight years and the mean number of cognitive assessments was five. The analysis revealed that a 1 mmol/mol increase in HbA1c was significantly associated with an increased rate of decline in global cognitive z scores, memory z scores and executive function z scores, all signs of cognitive function decline.

The results remained statistically significant even after adjustment for baseline age, sex, total cholesterol, HDL (good) cholesterol, triacylglycerol, high-sensitivity C-reactive protein, body mass index (BMI), education, marital status, depressive symptoms, current smoking, alcohol consumption, high blood pressure, heart disease, stroke, chronic lung disease and cancer.

While cognitive function declined with age (as expected) in all of the participants, whether diabetic or not, compared with participants with control, the global cognitive decline associated with prediabetes and diabetes was significantly increased. Similarly, memory, executive function and orientation z scores showed an increased rate of cognitive decline with diabetes.

Significantly, the rate of cognitive decline was directly linked to a person's HbA1c status (with higher HbA1c meaning higher rate of cognitive decline), whether or not they were diabetic according to their HbA1c status at baseline.

The authors say: "In conclusion, our study provides evidence to support the association of diabetes with subsequent cognitive decline. Moreover, our findings show a linear correlation between circulating HbA1c levels and cognitive decline, regardless of diabetic status. Future studies are required to determine the long-term effects of maintaining optimal glucose control on cognitive decline in people with diabetes...Our findings suggest that interventions that delay diabetes onset, as well as management strategies for , might help alleviate the progression of subsequent cognitive decline over the long-term."

Explore further: Glucose peaks linked to cognitive decline, dementia in diabetes

More information: Fanfan Zheng et al. HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing, Diabetologia (2018). DOI: 10.1007/s00125-017-4541-7

Related Stories

Glucose peaks linked to cognitive decline, dementia in diabetes

May 20, 2017
(HealthDay)—Glucose peaks are associated with cognitive decline and dementia among individuals with diabetes, according to a study published online May 12 in Diabetes Care.

Diabetes, poor glucose control associated with greater cognitive decline in older adults

June 18, 2012
Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a report published ...

Accelerated cognitive decline seen with T2DM in middle age

January 21, 2013
(HealthDay)—Middle-aged patients with type 2 diabetes show accelerated cognitive decline in information processing speed and executive function, according to a study published online Dec. 28 in Diabetes Care.

Effect of lowering blood pressure on risk for cognitive decline in patients with diabetes

February 3, 2014
Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study in JAMA Internal ...

Insulin resistance predicts later cognitive decline

April 10, 2017
(HealthDay)—Higher serum fasting insulin and insulin resistance predict poorer verbal fluency and a steeper decline in future verbal fluency, according to a study published online April 5 issue of Diabetes Care.

Study suggests improving blood sugar control could help prevent dementia in patients with type 2 diabetes

September 14, 2015
A study of 350,000 patients with type 2 diabetes shows that those with poor blood sugar control have 50% higher risk of being admitted to hospital in future for dementia as those with good control. The research, which suggests ...

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.